MP29-02*’s Advanced Delivery System Contributes to Its Efficacy in Patients With Moderate/Severe Seasonal Allergic Rhinitis
Clinical and Translational Allergy - United Kingdom
doi 10.1186/2045-7022-5-s4-p36
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Springer Science and Business Media LLC